Results 21 to 30 of about 486 (141)

Acneiform type of mogamulizumab-associated rash. [PDF]

open access: yesJ Dtsch Dermatol Ges
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 11, Page 1469-1471, November 2025.
Hansen-Abeck I   +5 more
europepmc   +2 more sources

Ofuji's disease in an immunocompetent patient successfully treated with dapsone

open access: yesIndian Dermatology Online Journal, 2016
Eosinophilic pustular folliculitis or Ofuji's disease is a non-infectious eosinophilic infiltration of hair follicles, which usually presents with itchy papules and pustules in a circinate configuration.
Gopikrishnan Anjaneyan   +3 more
doaj   +1 more source

Eosinophilic pustular folliculitis associated with Demodex overgrowth or demodicosis on the face – A report of five cases

open access: yesDermatologica Sinica, 2021
Eosinophilic pustular folliculitis (EPF) is classified into Ofuji disease, immunosuppression-associated EPF, and infancy-associated EPF. The association of EPF with Demodex infestation is rarely reported.
Hui-Peng Huang   +7 more
doaj   +1 more source

Eosinophilic Pustular Folliculitis

open access: yesArchives of Pathology & Laboratory Medicine, 2007
AbstractClassical eosinophilic pustular folliculitis, or Ofuji's disease, is a chronic and relapsing dermatosis that is predominantly reported in East Asian populations. Clinically, the disease typically begins as small papules, which enlarge and coalesce into a large plaque, usually on the face.
Wajiha, Sufyan   +3 more
openaire   +2 more sources

A Case of Ofuji Disease Successfully Treated with the Combination of Low-Dose Indomethacin and Topical Tacrolimus

open access: yesCase Reports in Dermatology, 2020
Eosinophilic pustular folliculitis (EPF) (Ofuji disease) is a chronic, noninfectious pruritic cutaneous disorder of unknown etiology. No official guidelines are available for its treatment.
Claudio Marasca   +3 more
doaj   +1 more source

Dermatoses neutrofílicas: parte II Neutrophilic dermatoses: part II

open access: yesAnais Brasileiros de Dermatologia, 2011
Neste artigo são abordadas as dermatoses neutrofílicas, complementando o artigo anterior (parte I). São apresentadas e comentadas as seguintes dermatoses: pustulose subcórnea de Sneddon-Wilkinson, dermatite crural pustulosa e atrófica, pustulose ...
Fernanda Razera   +2 more
doaj   +1 more source

Neonatal eosinophilic pustular folliculitis

open access: yesClinical and Experimental Dermatology, 2001
Abstract Eosinophilic pustular folliculitis (EPF) of infancy is a rare disorder which may begin in the neonatal period and cause considerable parental anxiety. It must be distinguished from other causes of a pustular eruption in neonates, including infection and erythema toxicum neonatorum, and rare disorders such as transient neonatal ...
D A, Buckley, S E, Munn, E M, Higgins
openaire   +2 more sources

Eosinophilic Pustular Folliculitis in a Patient With HIV Receiving Antiretrovirals

open access: yesAnnals of Internal Medicine: Clinical Cases
This case report describes eosinophilic pustular folliculitis in a patient with long-standing, well-controlled HIV. Eosinophilic pustular folliculitis is an uncommon inflammatory skin disease often associated with low CD4 counts and immune dysregulation ...
Shipra Goel, Mahak Bhatti
doaj   +1 more source

A hybrid case of eosinophilic folliculitis and eosinophilic cellulitis associated with hypereosinophilic syndrome. [PDF]

open access: yesSkin Health Dis
We report an atypical case of Wells syndrome in conjunction with rare eosinophilic disorders such as hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome). Abstract Eosinophilic cellulitis or Wells syndrome encompasses distinct histopathological features but can also be associated with eosinophilic ...
Iatropoulou D   +4 more
europepmc   +2 more sources

Review of Biological Agents in the Therapeutic Management of Monogenic Genodermatoses

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Monogenic genodermatoses encompass a diverse group of over 400 distinct disorders, presenting significant therapeutic challenges. Recent advancements in the clinical application of biological agents have heralded a new era in the management of these conditions.
Xueying Wang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy